GBM Awards Otto Warburg Medal to Prof. Randy Schekman
FRANKFURT, Germany, October 3, 2013
FRANKFURT, Germany, October 3, 2013 /PRNewswire/ --
50 ^th anniversary of the Otto Warburg Medal - half a century of recognising
On the Day of German Unity , the German Society for Biochemistry and Molecular
Biology (GBM) awarded the Otto Warburg Medal to Prof. Randy W. Schekman, an
American researcher of molecular and cell biology at the University of
California, Berkeley. The medal is internationally recognised and is
considered the highest German award in the fields of biochemistry and
Professor Schekman received the award for his research on the regulation of
protein transport processes in cells. He was able to demonstrate that
disturbances in these processes are the cause of several genetic diseases and
other genetic defects.
The GBM has been awarding the prestigious science prize, which is highly
regarded internationally, for the past 50 years. Seven of the former winners
have been awarded the Nobel Prize in the course of their career.
At the award ceremony in Frankfurt Professor Schekman was very pleased to
receive the Otto Warburg Medal, saying: "It is a great honour to receive such
a prestigious award and at the same time an enormous incentive to continue
with my research. There is still so much to be discovered and I hope that
winning this award will motivate many young people to become researchers."
Professor Schekman has been a professor of molecular and cell biology at the
University of California, Berkeley, since 1989 and also holds a professorship
in biochemistry and biophysics at the University of California, San Francisco.
"The GBM is proud to award the Otto Warburg Medal in its 50th anniversary year
to such a renowned researcher as Professor Schekman," said Professor Roger S.
Goody, President of the GBM. "This prize represents a long-standing tradition
in recognising and encouraging academic excellence. We are very happy that we
can celebrate the anniversary of the Otto Warburg Medal in Frankfurt amidst
many companions, friends and hopefully future winners."
The Otto Warburg Medal is endowed with 25,000 euros of prize money, which is
intended for further research activities. The academic publisher Elsevier and
its flagship journal Biochimica et Biophysica Acta (BBA), exclusively support
Angelika Lex, Vice President of Academic Relations at Elsevier, emphasised:
"Recognition of scientific achievements particularly serves to inspire the
next generation of researchers, which is very important to us. Our cooperation
with GBM enables us to accomplish this."
The Award Ceremony
Professor Randy W. Schekman was awarded the Otto Warburg Medal on Thursday, 03
October, at 3:00 pm during the Molecular Life Sciences Symposium (
http://www.molecular-life-sciences.de/ ). After accepting the medal, he spoke
about his research.
The Otto Warburg Medal celebrates its 50 ^th anniversary and has been awarded
by the German Society for Biochemistry and Molecular Biology (Gesellschaft für
Biochemie und Molekularbiologie, GBM) since 1963. It honours and encourages
pioneering achievements in fundamental biochemical and molecular biological
research. Discoveries in these scientific disciplines are a prerequisite for
the development of, e. g., novel medicines. The Otto Warburg Medal is regarded
as the highest award for biochemists and molecular biologists in Germany.
Seven of the prize-winners have also received the Nobel prize. The Medal has
been endowed with 25,000 euros of prize money since 2007, sponsored
exclusively by Elsevier and its flagship title Biochimica et Biophysica Acta
(BBA). For further information on the medal visit
The German Society for Biochemistry and Molecular Biology (Gesellschaft für
Biochemie und Molekularbiologie, GBM) is the largest organisation for life
sciences in Germany. With its almost 5,500 members, it is committed to serving
the interests of all those working and researching in the dynamic and
promising disciplines of chemistry, medicine and biology - from professors to
first-year students. Whether it is the German Research Foundation (Deutsche
Forschungsgemeinschaft), journalists, the authorities, or professional
associations in other disciplines: anyone needing to call on expertise in
questions of biochemistry and molecular biological sciences turns first and
foremost to the GBM. For further information visit http://www.gbm-online.de/ .
Elsevier is a world-leading provider of scientific, technical and medical
information products and services. The company works in partnership with the
global science and health communities to publish more than 2,000 journals,
including The Lancet and Cell , and close to 20,000 book titles, including
major reference works from Mosby and Saunders. Elsevier's online solutions
include ScienceDirect , Scopus , SciVal , Reaxys , ClinicalKey and Mosby's
Suite , which enhance the productivity of science and health professionals,
helping research and health care institutions deliver better outcomes more
A global business headquartered in Amsterdam, Elsevier employs 7,000 people
worldwide. The company is part of Reed Elsevier Group plc , a world leading
provider of professional information solutions. The group employs more than
30,000 people, including more than 15,000 in North America. Reed Elsevier
Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed
Elsevier NV. Their shares are traded on the London, Amsterdam and New York
Stock Exchanges using the following ticker symbols: London: REL; Amsterdam:
REN; New York: RUK and ENL.
About Biochimica et Biophysica Acta (BBA)
Biochimica et Biophysica Acta, launched in 1947, remains the only
international journal devoted to the joint fields of biochemistry and
biophysics. Initially papers were published in English, French, and German.
Today BBA comprises nine different journals, each with unique editors and
scope and an average impact factor above 5. The members of the American
Library Association recognized BBA's outstanding value in 2009 by electing BBA
to the 100 Most Influential Journals in Biology & Medicine over the last 100
Media contact: Dr. Anke Lischeid Managing Director, GBM +49-69-660567-12
Press spacebar to pause and continue. Press esc to stop.